|
Originally published In Press as doi:10.1194/jlr.M800622-JLR200 on January 14, 2009
Journal of Lipid Research, Vol. 50, 894-907, May 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
Frank M. Sacks1,*, ,
Lawrence L. Rudel ,
Adam Conner ,
Hassibullah Akeefe ,
Gerhard Kostner**,
Talal Baki ,
George Rothblat ,
Margarita de la Llera-Moya ,
Bela Asztalos ,
Timothy Perlman ,
Chunyu Zheng*, ,
Petar Alaupovic***,
Jo-Ann B. Maltais and
H. Bryan Brewer , 
* Harvard School of Public Health and Harvard Medical School, Boston, MA
Wake Forest University Health Sciences, Winston-Salem, NC
Lipid Sciences Incorporated, Pleasanton, CA
** Medical University of Graz, Graz, Austria
 Children's Hospital of Philadelphia, Philadelphia, PA
 Tufts University, Boston, MA
*** Oklahoma Medical Research Foundation, Oklahoma City, OK
  Medstar Research Institute, Washington Hospital Center, Washington, DC
The research was conducted at Lipid Sciences (Adam Conner, Hassibulah Akeefe, Timothy Perlman, Dr. Maltais); and at Wake Forest University (Drs. Rudel and Baki), University of Graz (Dr. Kostner), Children's Hospital of Philadelphia (Drs. Rothblat and de la Llera-Moya), Tufts University (Dr. Asztalos), and Oklahoma Medical Research Foundation (Dr. Alaupovic), funded by grants from Lipid Sciences. The monkey atherosclerosis progression study was funded by a National Institutes of Health grant to LLR, HL-24736.
Published, JLR Papers in Press, January 14, 2009.
1 To whom correspondence should be addressed. e-mail: fsacks{at}hsph.harvard.edu
Uptake of cholesterol from peripheral cells by nascent small HDL circulating in plasma is necessary to prevent atherosclerosis. This process, termed reverse cholesterol transport, produces larger cholesterol-rich HDL that transfers its cholesterol to the liver facilitating excretion. Most HDL in plasma is cholesterol-rich. We demonstrate that treating plasma with a novel selective delipidation procedure converts large to small HDL [HDL-selectively delipidated (HDL-sdl)]. HDL-sdl contains several cholesterol-depleted species resembling small , preβ-1, and other preβ forms. Selective delipidation markedly increases efficacy of plasma to stimulate ABCA1-mediated cholesterol transfer from monocytic cells to HDL. Plasma from African Green monkeys underwent selective HDL delipidation. The delipidated plasma was reinfused into five monkeys. Preβ-1-like HDL had a plasma residence time of 8 ± 6 h and was converted entirely to large -HDL having residence times of 13–14 h. Small -HDL was converted entirely to large -HDL. These findings suggest that selective HDL delipidation activates reverse cholesterol transport, in vivo and in vitro. Treatment with delipidated plasma tended to reduce diet-induced aortic atherosclerosis in monkeys measured by intravascular ultrasound. These findings link the conversion of small to large HDL, in vivo, to improvement in atherosclerosis.
Supplementary key words apolipoprotein A-I kinetics lipoproteins nonhuman primates ABCA1 SRB1 preβ-1

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|